Literature DB >> 4918551

Observation on the mechanism of renin release by hydralazine in hypertensive patients.

H Ueda, Y Kaneko, T Takeda, T Ikeda, S Yagi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4918551

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  14 in total

Review 1.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

2.  [Importance of the sympathico-adrenal system in renin release].

Authors:  K A Meurer
Journal:  Klin Wochenschr       Date:  1971-09-15

3.  Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol.

Authors:  I B Davies; P S Sever; T Rosenthal
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

4.  Increased levels of prostaglandin-like material in the canine blood during arterial hypotension produced by hydralazine, dihydralazine and minoxidil.

Authors:  G Haeusler; M Gerold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

5.  Altered renin release and propranolol potentiation of vasodilatory drug hypotension.

Authors:  W A Pettinger; K Keeton
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

6.  Plasma renin concentration in essential hypertension during beta-adrenergic blockade and vasodilator therapy.

Authors:  E B Pedersen; H J Kornerup
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

7.  Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and cats.

Authors:  M F Sim; D B Yates; R Parkinson; M J Cooling
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

Review 8.  Calcium antagonists and exercise performance.

Authors:  W Kindermann
Journal:  Sports Med       Date:  1987 May-Jun       Impact factor: 11.136

9.  Effects of indomethacin and (+/-)-propranolol on the cardiovascular and renin responses to vasoactive intestinal polypeptide (VIP) infusion in man.

Authors:  R J Unwin; T Reed; S Thom; J Calam; W S Peart
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

10.  Effect of propranolol on sympathetic nervous activity in hydrallazine-treated hypertensive patients.

Authors:  M Velasco; E Romero; H Bertoncini; A Urbina-Quintana; J Guevara; O Hernández-Pieretti
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.